Volume 9, Number 9—September 2003
Research
Epidemic and Nonepidemic Multidrug-Resistant Enterococcus faecium
Helen L. Leavis*†, Rob J.L. Willems†, Janetta Top†, Emile Spalburg†, Ellen M. Mascini*, Ad C. Fluit*, Andy Hoepelman*, Albert J. de Neeling†, and Marc J.M. Bonten*
Table 1
Description of studied Enterococcus faecium isolates
| Origin |
Country |
n |
|---|---|---|
| Vancomycin-resistant E. faecium | ||
| Epidemic |
United Kingdom |
1 |
| Netherlands |
4 |
|
| United States |
11 |
|
| Clinical infections |
Austria |
1 |
| United Kingdom |
7 |
|
| Israel |
2 |
|
| Italy |
1 |
|
| Netherlands |
8 |
|
| United States |
1 |
|
| Clinical surveillance |
Germany |
1 |
| France |
4 |
|
| United Kingdom |
1 |
|
| Israel |
1 |
|
| Italy |
1 |
|
| Netherlands |
27 |
|
| Slovenia |
1 |
|
| Community surveillance |
United Kingdom |
1 |
| Netherlands |
35 |
|
| Vancomycin-susceptible E. faecium |
||
| Clinical infections |
Austria |
6 |
| Belgium |
1 |
|
| Switzerland |
3 |
|
| Germany |
14 |
|
| Spain |
8 |
|
| France |
8 |
|
| United Kingdom |
1 |
|
| Greece |
1 |
|
| Italy |
16 |
|
| Poland |
5 |
|
| Portugal |
5 |
|
| Turkey |
5 |
|
| Clinical surveillance |
Netherlands |
5 |
| Community surveillance | Netherlands | 14 |
